In line with previous results [23–26, 50], we confirmed that MMP-2 is expressed in astrocytomas with the highest level in GBMs and found that high levels of MMP-2 were inversely related to survival in patients with grade II-IV astrocytic tumors. Here, MMP2 is linked to astrocytic tumor.